Herpes zoster associated neuralgia
Conditions
Interventions
group A (poor prognosis):None
Group B (favorable prognosis):none
Group C (Control):none
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: ((1) Age between 18 and 90 years; (2) Healthy patients were defined as patients with no history of disease other than diabetes or hypertension; (3) ZAN patients scheduled for neuromodulation therapy.
Exclusion criteria
Exclusion criteria: (1) Patients with other pain-related diseases; (2) Patients with other diseases causing central or peripheral nerve injury; (3) Patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, infectious diseases and other contraindications to minimally invasive interventional therapy; (4) Uncontrolled mental disorders and communication disorders; (5) Patients who refuse to be followed up or are lost to follow-up 3 months after surgery; (6) Patients who undergo minimally invasive interventional therapy again within 3 months after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| galectin-3;NRS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease duration;Pain Location;Concomitant disease;Complication;C-reactive protein;Erythrocyte sedimentation rate; | — |
Countries
China
Contacts
Public ContactHong Liu
The First Affiliated Hospital of Soochow University
Outcome results
None listed